Home LiteratureArticle Details
PMID: 6438048 Published · ppublish English Clinical Trial Comparative Study Controlled Clinical Trial Journal Article Randomized Controlled Trial

A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.

The Journal of antimicrobial chemotherapy ·Vol. 14 Suppl C ·1984-09-00 ·Pages 91-4

Notowicz A, Stolz E, van Klingeren B

Abstract

A double blind pilot study was done to compare the efficacy and safety of treatment of uncomplicated gonorrhoea with two dosages of enoxacin. Eleven patients were treated with 600 mg enoxacin as a single oral dose and eleven patients were given 400 mg twice with an interval of 4 h. A cure rate of 100% was found with both dosages. No side effects were noted and there were no abnormalities in haematological tests or renal and hepatic function tests after treatment. MIC's of enoxacin and other relevant antibiotics were determined. A single oral dose of 600 mg enoxacin seems sufficient to cure uncomplicated gonorrhoea and warrants further investigation in more patients.

MeSH Terms
Adult Aged Clinical Trials as Topic Double-Blind Method Drug Resistance, Microbial Enoxacin Female Gonorrhea/drug therapy,microbiology Humans Male Middle Aged Naphthyridines/administration & dosage,therapeutic use Neisseria gonorrhoeae/drug effects Random Allocation
Chemicals
Naphthyridines Enoxacin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Notowicz A
Stolz E
van Klingeren B
Article Info
Journal
The Journal of antimicrobial chemotherapy
Abbr.
J Antimicrob Chemother
ISSN
0305-7453
Published
1984-09-00
Pages
91-4
Language
English
Region
England
NLM ID
7513617
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]